Protein Kinase M Zeta-Mediated LTP Maintenance in the Non-Human Primate Hippocampus: A role for Stress and Serotonergic Signaling in Affective Processing by Fulton, Sasha L
City University of New York (CUNY) 
CUNY Academic Works 
School of Arts & Sciences Theses Hunter College 
Fall 12-21-2016 
Protein Kinase M Zeta-Mediated LTP Maintenance in the Non-
Human Primate Hippocampus: A role for Stress and Serotonergic 
Signaling in Affective Processing 
Sasha L. Fulton 
CUNY Hunter College 
How does access to this work benefit you? Let us know! 
More information about this work at: https://academicworks.cuny.edu/hc_sas_etds/120 
Discover additional works at: https://academicworks.cuny.edu 
This work is made publicly available by the City University of New York (CUNY). 
Contact: AcademicWorks@cuny.edu 
 1 
Protein Kinase M Zeta-Mediated LTP Maintenance in the Non-Human Primate 
Hippocampus: A role for Stress and Serotonergic Signaling in Affective Processing 
by 
Sasha Fulton 
Submitted in partial fulfillment 
of the requirements for the degree of 
Master of Arts in Biological Sciences, Hunter College 
The City University of New York 
2016 




December 21, 2016  Dr. Jeremy Coplan 
Date  Signature 
 
December 21, 2016   Dr. Thomas Schmidt-Glenewinkel 




Project Summary:  
Early Life Stress (ELS) is associated with an increased vulnerability to developing 
mood disorder later in life (35). While many of the structural and neurochemical 
consequences of ELS have been studied, it is not well understood how these 
changes may translate to the deficits in cognitive and affective function associated 
with mood disorders. The constitutively active Protein Kinase C kinase isoform 
Protein Kinase M zeta (PKMzeta) has a critical role in the molecular mechanisms of 
long-term potentiation (LTP) maintenance (1, 2), and memory storage. Recent 
preclinical studies indicate PKMzeta expression at the synaptic membrane directly 
mediates cognitive processing in the hippocampus (33, 34). Building on our previous 
findings of serotonergic dysfunction and hippocampal hypotrophism in the highly 
clinically relevant Variable Foraging Demand (VFD) Non-Human Primate (NHP) 
model of ELS, the current study aims to further characterize the ELS phenotype with 
respect to this key marker of hippocampal LTP. Furthermore, we have recently 
presented evidence of impaired neurogenesis in the VFD dentate gyrus compared to 
non-VFD reared animals subjected to chronic adult stress (93) suggesting that ELS 
and concurrent adult stress affect hippocampal processes differentially. In the 
current report, we utilize our extensive NHP tissue bank, which includes 
hippocampal samples from animals subjected to ELS and chronic adult stress, 
respectively, in order to explore these differential effects of ELS vs. concurrent stress 
on hippocampal LTP, and the implications of those effects on cognitive aspects of 
stress-related depressive symptoms in NHPs.  
This is the first report of PKMzeta detection and analysis in the NHP brain – an 
important model for translational psychiatric research. We hypothesize that ELS 
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rearing is associated with reduced PKMzeta expression, and that this effect may be 
linked to cognitive deficits often observed in animal and clinical studies of ELS. 
Semi-quantitative evaluation of PKMzeta signal intensity via neuroimmunostaining 
across defined subregions in the NHP hippocampus will allow us to assess the 
effects of differential rearing conditions and stress paradigms on key components of 
hippocampal LTP maintenance as a consequence of ELS versus concurrent adult 
stress. We further hypothesize, based on recent mechanistic reports, that PKMzeta 
expression in the hippocampus is interconnected with both serotonergic signaling 
and Brain-derived Neurotrophic Factor (BDNF) expression – two critically important 
processes involved in hippocampal function (94). Importantly, our NHP cohort 
includes bonnet macaques harboring both the “long” and “short” alleles of the 
serotonin transporter gene polymorphism. The “short” STG allele produces a 
functional serotonin transporter with reduced capacity leading to reduced serotonin 
signaling, allowing us to observe how impaired serotonergic signaling may interact 
with rearing conditions to affect expression of these markers.  
Finally, we hypothesize that reduced PKMzeta in ELS subjects may manifest in 
behavioral alterations in adulthood. Previous studies in rodents and primates have 
definitively shown that PKMzeta expression in the hippocampus has a direct effect 
on cognition and behavior (33, 34). Thus, by correlating hippocampal PKMzeta 
signal intensities with previously obtained behavioral data from this same cohort, we 
aim to delineate the neurobiological phenotype of altered hippocampal processing in 
the NHP model of ELS – further linking the distribution and activity of the molecular 
substrate of L-LTP to its behavioral and physiological manifestations. 
While many studies have utilized PKMzeta localization as a tool for identifying 
maintenance of spatial memory in the rodent dorsal hippocampus (20), few have 
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examined the distribution of PKMzeta in the non-human primate brain or attempted 
to investigate the role of PKMzeta in the affective processing circuits of the 
hippocampus (25). Nonhuman primates provide a powerful model in which to use 
postmortem analyses to identify the mechanisms by which early stress and genetic 
makeup interact to produce long-term changes in brain development, stress 
reactivity, and risk for psychiatric disorders. Improved understanding of these 
processes will likely lead to the development of novel strategies for the prevention 
and treatment of neuropsychiatric disorders. 
 
Specific Aims: 
1. Assess differential patterns of PKMzeta expression in the NHP hippocampus by 
quantifying average PKMzeta signal intensity in specific subregions to detect 
alterations in VFD animals compared to control. We are particularly interested in 
exploring the role of serotonergic signaling, a key monoamine implicated in 
depression, in mediating PKMzeta expression. We will examine PKMzeta signal 
intensity in differentially reared subjects harboring the “Long” versus “Short” 
polymorphic alleles of the Serotonin Transporter Gene (STG) promoter.  
2. Determine how PKMzeta expression in VFD subjects compares to hippocampal 
PKMzeta expression in concurrent adult stress subjects, in order to finely define 
specific phenotypes of early life stress versus adult stress. 
3. Quantify the BDNF concentration in key sub-groups of our extensive NHP cohort in 
order to determine if there is a relationship between PKMzeta and BDNF expression, 
potentially indicating a role for neurotrophic deficits in the cognitive symptoms of 
stress-induced affective dysregulation. Results from this analysis may indicate if the 
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neurobiological alterations we have previously observed in VFD models of ELS are 
associated with cognitive processes. 
4.  Correlate previously collected data, including maladaptive behavioral response to 
intruder stressors, from this same cohort of NHPs to the quantification of PKMzeta 
concentration distribution across the hippocampus with the goal of determining the 
extent to which the consistent VFD maladaptive behavioral phenotype is linked to 
LTP maintenance in the hippocampus.  
 
Background:  
Protein Kinase M Zeta and the Molecular Mechanisms of LTP Maintenance  
Molecular Mechanism of PKMzeta in LTP maintenance  
One of the most exciting recent discoveries in the field of molecular neuroscience is 
the identification of constitutively active atypical PKC kinase isoform PKMzeta as a 
critical factor in the molecular mechanism of late-phase long-term potentiation (LTP) 
maintenance (1,2). LTP is an activity-dependent and persistent strengthening of 
synaptic transmission, and one of the most likely candidate processes underlying 
long-term memory (3). This potentiation is achieved through a complex set of 
intracellular molecular signaling cascades that ultimately converges on the synaptic 
machinery responsible for increasing the number of excitatory α-amino-3-hydroxy-5-
methyl-4-isoxazolepropionic acid glutamate receptors (AMPAR) in the post-synaptic 
density of the neuronal cell membrane (4).  LTP can be separated into two distinct 
phases: the initial induction phase triggers potentiation, and involves the rapid 
synthesis and activation of calcium-dependent proteins to quickly enact the structural 
and proteomic changes required for modulating synaptic plasticity (5,6). Importantly, 
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many of the molecules that were discovered to be important to forming long-term 
memory, such as neurotransmitters and their receptors, Ca2+-dependent second 
messenger kinases, and downstream transcription factors and growth effectors were 
found to be critical for LTP induction, but not required for the second and longer-
lasting maintenance phase (76). Inhibiting any of these LTP induction factors does 
not affect storage of previously consolidated memory (6, 76). Instead, the process of 
LTP induction is thought to coincide with memory encoding, while the second and 
longer-lasting LTP maintenance phase sustains storage of a distributed long-term 
memory engram (6). Recently, it was discovered by Dr. Todd Sacktor’s group at 
SUNY Downstate that the persistently active protein kinase C isoform PKMzeta is 
both necessary and sufficient to maintain LTP and memory storage (8,19). This 
atypical PKC isoform has several unique characteristics that specify its central 
function in sustaining synaptic potentiation. PKMzeta is exclusively expressed in 
brain tissue and is specifically enriched in the forebrain, particularly in the 
hippocampus and neocortex (9). Furthermore, the PKMzeta isoform is transcribed 
from an internal promoter at the PKC locus, and thus lacks the autoinhibitory domain 
of typical PKC molecules, allowing it to autonomously and continuously 
phosphorylate its target substrates (10).  Importantly, this unique persistent catalytic 
activity is the basis for PKM z’s role in long-term LTP maintenance. 
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Figure 1: Shows a graphic model of the inactive and active conformations of the typical PKC kinase 
and the truncated PKM. PKC consists of a C-terminal catalytic domain (green) tethered by a hinge (yellow) 
to an N-terminal regulatory domain (red), which contains an autoinhibitory pseudosubstrate sequence. PKC 
is maintained in an inactive state by the interaction between the pseudosubstrate and the catalytic site. PKC 
is activated by second messengers, which produce a conformational change that releases the autoinhibition. 
PKM is the independent catalytic domain of PKC, synthesized from an internal promoter at the PKC gene 
locus. Because PKM lacks a regulatory domain, it is constitutively active. [Taken from Ref. 73] 
  
 
Figure 2: PKMζ mRNA formation from an internal promoter within the PKCζ gene : The intron-exon 
structure of the human PKCZ gene shows two exon clusters separated by a large intron: exons 1-4, 
encoding the PKCZ 5’UTR (in light blue) and regulatory domain ( in red), and exons 5-18, encoding the 
remaining regulatory domain, hinge (yellow), catalytic domain (green), and 3’ UTR (grey). The unique 5’ 
PKMζ mRNA sequence is in a single exon (exon 1’, dark blue) within the large intron. PKCζ mRNA 
transcription begins at exon 1. PKMzeta transcription is initiated from exon 1’ and alternative splicing to exon 
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5 generates PKMζ mRNA. [Taken from Ref. 73] 
 
 
At the synapse, the strength of signal transmission between two neurons is tightly 
regulated to preserve relevant connections and degrade irrelevant ones. At resting 
state, α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors (AMPARs) 
cation channels are a main regulator of synaptic membrane depolarization 
thresholds and are constantly removed from the membrane and targeted for 
degradation by the ubiquitin-proteasome pathways that work to recycle proteins in 
the dendritic compartment (9). The constitutive PKMzeta kinase appears to sustain 
LTP maintenance after induction through regulating AMPA Glutamate receptor 2 
(GluR2)-subunit dependent ionotropic receptor trafficking at the post-synaptic 
density (10) and preventing AMPAR endocytosis and degradation, in order to 
generate non-decaying LTP (11). The mechanistic details of this process are just 
now beginning to be understood: PKMzeta interacts directly with activity-dependent 
factors that traffic excitatory AMPA-glutamate receptors to the membrane during LTP 
induction (12). The kinase maintains LTP by acting on the N-ethylmaleimide-
sensitive factor (NSF) - Protein Interacting with C Kinase – 1 (PICK1) AMPA 
receptor trafficking pathway to increase intracellular trafficking of the GluR2 subunit-
containing AMPA receptor to the postsynaptic density following LTP induction, 
thereby potentiating the postsynaptic intracellular response to future excitatory 
neurotransmitter signaling at a given synapse (9,13).  
In the past few years, mounting evidence has demonstrated the importance 
of PKMzeta in LTP maintenance and long-term memory storage. Many of these 
studies have utilized the ζ-pseudosubstrate inhibitory peptide (ZIP), a specific 
inhibitor of PKMzeta, to disrupt PKMzeta activity. In a wide range of preclinical 
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investigations, microinjection of ZIP into specific brain regions abolishes both spatial 
memory and fear conditioned memories for up to three months post-training, far 
longer than the average half-life of the PKMzeta protein (14,15). In order to preserve 
synaptic potentiation for these long periods, PKMzeta must be continuously 
produced and upregulated locally to constantly work against this recycling process in 
neurons actively participating in long-term memory, (16) thus making it an excellent 
potential marker of long-term information storage and preferred processing pathways 
in memory circuitry.  
 
Figure 3: Model of LTP maintenance by PKMζ synthesis. Activation by the excitatory 
neurotransmitter glutamate (Glu) at the NMDA receptor (NMDAR) during a tetanus triggers the induction of 
PKMζ formation. PKMζ phosphorylation potentiates α-amino-3-hydroxy-5-methyl-4-isoxazolepropionate 
receptor (AMPAR) mediated synaptic transmission in LTP maintenance. Formation of PKMζ during LTP 
occurs through increased de novo protein synthesis from the PKMζ mRNA, produced by a dedicated internal 
promoter within the PKCζ gene. Potential activity-dependent regulatory mechanisms for PKMζ formation 




PKMzeta as a Marker of Neuronal Activation and Potential Indicator of Memory 
Engram 
PKMzeta is preferentially expressed in the hippocampus as a downstream target of 
many major signaling cascades in response to neuronal activation (1). Since the 
identification of PKMzeta as the major synaptic molecule responsible for LTP 
maintenance, two contrary studies have suggested that PKMzeta null mice are still 
capable of maintaining long-term memory (17), implying that the ZIP inhibitor of 
PKMzeta used to validate its critical role in long-term memory may act 
nonspecifically to disrupt proteins other than PKMzeta (18). Until recently, these 
reports cast doubt on the central role of PKMzeta in LTP maintenance. However the 
latest investigation into this process has now supplied definitive evidence that in 
these PKMzeta null mice, alternative atypical PKMs are able to compensate for 
PKMzeta function, thus reinstating PKMzeta as the endogenous mechanism for LTP 
maintenance. Tsokas et. al. (19) circumvented the use of potentially problematic off-
target effects of ZIP by synthesizing an antisense RNA to efficiently degrade and 
Knock-Down (KD) both PKMzeta and its closely related family members, Protein 
Kinase M Delta and Iota (PKMdelta and PKMiota). The authors show that in 
PKMzeta null mice, long-term memory does indeed remain intact (17,18). However, 
when the alternate atypical PKMs are also depleted in these same PKMzeta null 
mice, long-term memory is inhibited. Furthermore, in wild-type (WT) mice, depletion 
of alternate PKMzeta had no effect on long-term memory. Taken together, these 
data confirm that PKMzeta is required to maintain LTP and long-term memory, but 
that in the absence of PKMzeta, alternate mechanisms are recruited to perform LTP 
maintenance (19).  
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At the circuit level, PKMzeta’s role in LTP maintenance has been confirmed in 
a wide range of brain regions known to be involved in various types of memory. In 
the hippocampus, PKMzeta mediates place memory, spatial learning, and object 
recognition (14, 20, 21).  Injection of ZIP into the amygdala disrupts hippocampal-
dependent fear memory in rats, (22) and fear potentiated startle (23).  In the rodent 
reward centers of the brain, the Ventral Tegmental Area (VTA) and the Nucleus 
Accumbens (NAc), ZIP infusion alters cocaine sensitization and reduces memory for 
cocaine preference (24). In addition to using PKMzeta inactivation and 
overexpression to characterize PKMzeta function, many of these studies have 
demonstrated that intracellular PKMzeta protein expression positively correlates with 
specific memory retention (assessed behaviorally) and strengthened neuronal 
connectivity (assed electrophysiologically) in mice models (20, 21, 22).  
A more recent study found that while fear learning paradigms induced 
PKMzeta expression in the hippocampi of young control rats, this increase in 
PKMzeta was significantly reduced in aged rats. The PKMzeta reduction in aged rats 
was associated with cognitive impairment on several behavioral assessments, and 
was linked to increased cytosine methylation of the PKMzeta internal promoter loci 
(33). Furthermore, PKMzeta expression appears to be critically related to cognitive 
performance – both overexpression of PKMzeta and enriched environment improved 
cognitive performance in aged rats to a similar degree (33). However, in aged rats 
harboring a dominant negative version of PKMzeta, the loss of PKMzeta function 
prevented any improvement in performance after enriched environment (33), 
demonstrating the direct connection between PKMzeta expression levels and 
cognitive performance.   
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Overall, while many studies have utilized PKMzeta localization as a tool for 
identifying maintenance of spatial memory in the rodent dorsal hippocampus (20), 
few have examined the distribution of PKMzeta in the non-human primate brain or 
attempted to investigate the role of PKMzeta in the affective processing circuits of 
the ventral hippocampus (25). 
 
Protein Kinase M Zeta and Affective Processing in the Hippocampus 
Stress and Affective Processing in the Hippocampus 
The hippocampus is a key structure in the limbic system with an anterior segment 
(homologous to the ventral region in rodents) that mediates affective response to 
contextual changes in environment, and a posterior segment (homologous to dorsal 
region in rodents) that modulates spatial navigation and memory (26). Extremely 
sensitive to stress, hippocampal function is closely associated with affective 
disorder, with extensive afferent and efferent connections to limbic structures that 
regulate mood and cognition (71), such as the amygdala and ventromedial prefrontal 
cortex (vmPFC) (95). In both clinical and animal models of depression, researchers 
have found decreased hippocampal volume, reduced hippocampal activity, 
hypothalamic-pituitary axis (HPA) hyperactivity (indicative of hippocampal 
dysfunction) and reduced neurogenesis in the dentate gyrus (27-30). In addition, 
significant subsets of patients with major depressive disorder present with cognitive 
deficits, which can be recapitulated by inducing hippocampal lesions in nonhuman 
primates (31, 32).  
Given the large number of studies validating the role of the hippocampus in these 
processes, we aim to examine if PKMzeta expression can be used as a marker for 
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LTP and information storage integrity in these pathways. Two recently published 
reports support the relevance of PKMzeta in both cognitive and affective processing 
in the hippocampus. The first, by Hara et. al. (33) is particularly relevant for its use of 
the rhesus monkey as a model organism to examine the connection between 
PKMzeta subcellular localization and performance on cognitive and memory tasks. 
This study looked at perforant spines in the dentate gyrus of aged monkeys and 
found decreased density of synaptic GluA2 spines co-expressing PKMzeta 
compared to young monkeys – a deficit that correlated with impaired recognition 
memory (33). They found that the total densities of PKMzeta in dentate gyrus 
dendritic spines significantly correlated with both acquisition and performance on a 
delayed nonmatching-to-sample memory (DNMS) task, where monkeys with higher 
PKMzeta densities learned the task more rapidly and more accurately (33).  
The second study utilized a rodent model of PTSD called re-stressed SPS to show 
that hippocampal PKMzeta can mediate anxiety and depressive behaviors related to 
this disorder (34). By modifying the classical SPS paradigm for modeling PTSD in 
rats to include a re-exposure to the original stressful context, the authors were able 
to more fully recapitulate PTSD symptomology in their subjects, resulting in impaired 
extinction of contextual fear, enhanced glucocorticoid negative feedback, and 
increased anxiety-like behavior (34).  In re-stressed SPS rodent subjects, the 
authors observed a 3x increase in PKMzeta protein and PKMzeta mRNA transcripts 
in the hippocampus compared to control animals correlating with enhanced 
depressive or anxiety-like behaviors (34). Next, they found that inhibiting PKMzeta 
by administering ZIP into the hippocampus alleviated these depressive and anxiety-
like responses in re-stressed SPS animals while not significantly affecting these 
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same measures in control animals (34), suggesting that PKMzeta-dependent  LTP 
mediates these affective responses in the hippocampus.  
Given these findings, we intend to utilize PKMzeta as a marker for LTP maintenance 
in the non-human primate hippocampus in order to characterize its role in cognition 
and affective processing. Our unique and extensive non-human primate brain tissue 
bank contains whole brain slices from subjects with a wide range of experimental 
and developmental conditions, most notably Early Life Stress (ELS) rearing 
paradigms. A series of studies has provided a mounting body of evidence that ELS 
may confer susceptibility to psychiatric disorder later in life (35). Given its importance 
in the pathophysiology of affective disorder, we aim to determine the effects of ELS 
on PKMzeta expression in the hippocampus.  
 
A Putative Role for Protein Kinase M Zeta in the Pathophysiology of 
Affective Disorders  
Early Life Stress is a Risk Factor for Affective Disorder 
Early life stress (ELS) exerts a profound influence on behavior and physiology, 
putting victims at risk for depression, anxiety disorders and substance abuse (35-
38). Indeed, ELS not only increases the risk for developing these disorders later in 
life, but may also increase the likelihood of comorbidity and resistance to clinical 
treatment (39-42). In order to examine the effects of early life adversity, our 
laboratory has developed and characterized the Variable Foraging Demand (VFD) 
model of ELS in bonnet macaques (43). In the VFD model, mother-infant dyads are 
presented with unpredictable variations in the ease of food accessibility. Using 
foraging carts, food is either readily accessible to the mother (low foraging demand) 
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or more difficult to obtain (high foraging demand). This unpredictability leads to 
maternal neglect of the infant, generating a translational model of human anxiety and 
mood disorder in the offspring (44-48). These subjects have psychological 
symptoms similar to those in patients with anxiety and mood disorders: blunted 
affect, diminished capacity for affiliative engagement, and social subordinance (71). 
Using this paradigm, we have found significant neurobiological alterations in the 
central nervous system and peripheral tissues post-ELS conditioning that may 
underlie its capacity as a major risk factor for affective disorders into adulthood. 
These stress-related abnormalities in VFD versus non-VFD animals include: altered 
monoamine neurotransmission (43,45,49), impaired hippocampal neurogenesis (50), 
maladaptive behavioral response to acute stressors (51, 52), abnormal regional 
activation via MRI imaging (53), and neuroanatomical changes including reduced 
hippocampal size (54). Thus, by correlating hippocampal PKMzeta 
neuroimmunological signal intensities with previously obtained behavioral data from 
this same cohort, we can delineate the neurobiological phenotype of altered 
hippocampal processing in the NHP model of ELS -- effectively linking the 






Variable Foraging Demand Rearing Procedure: Mother-infant dyads were group-
housed in pens of 5–7 dyads each, and stabilized for at least 4 weeks prior to VFD 
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onset (74). After infants reached at least 2 months of age, dyads were subjected to a 
standard VFD procedure that involved 8 alternating 2-week blocks in which maternal 
food was readily obtained (LFD) or more difficult to access (high foraging demand; 
HFD). During HFD conditions, the mothers had to find food by digging through clean 
wood-chip in a foraging cart. Food can be accessed by mothers through apertures in 
the sides of the foraging cart. In the control non-VFD condition, the mothers' food 
access was continuous. Adequate food was always available under both conditions, 
and there were no differences in weight between VFD and non-VFD mothers or 
infants. However, the unpredictability of foraging conditions putatively prevented 
VFD mothers from adequately attending to their infants. The early-life stress 
paradigm putatively occurs through the disruption of normative patterns of maternal 
rearing and infant attachment (45). After infancy, no experimental manipulations 
occur that may confound the VFD-rearing effects. 
Females:  
Adult female bonnet macaques were matched based on age, weight, social rank, 
and timing of menstruation, and randomized to a Control pen (n = 6) or a Stress pen 
(n = 6).  
Separation Stress: Using the chronic stress paradigm developed in rhesus 
macaques, we exposed subjects in the Stress pen to social isolation for two days 
followed by social reunion on the remaining 5 days, repeated for a total duration of 
15 weeks. The monkeys in the Control pen remained in social housing for those 15-
weeks.  
Fluoxetine: During this period, half the subjects in each pen (Control-Drug and 
Stress-Drug groups) were treated with the selective serotonin reuptake inhibitor 
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(SSRI), fluoxetine. In order to minimize the stress of administration, we used Prozac-
weekly preparation (Eli Lilly Corp.), at a dose of 13.5 mg/kg infused via nasogastric 
tube (NGT) under sedation (ketamine 5 mg/kg and xylazine 1 mg/kg), once per week 
for 15-weeks. This dose was equivalent to a daily dose of 2 mg/kg of the drug. The 
remaining half (Control-Placebo and Stress-Placebo) received the same treatment 
with saline placebo via NGT.  
Sacrifice: All groups were injected with the thymidine analog bromodeoxyuridine 
(BrdU) (100 mg/kg/day, I.V.) under ketamine/xylazine sedation for 5 days during 
week-7 of intervention (Stress/Control+Drug/Placebo) and then sacrificed by 
transcardiac perfusion with normal saline (500 ml/kg) followed by 4% 
paraformaldehyde (500 mg/kg) under deep anesthesia with pentobarbital (15 mg/kg, 
I.V.) on week-16 of interventions. 
 
Behavioral Measures of Emotional Reactivity 
Each animal was individually exposed briefly to an intruder, a fear-stimulus which is 
a variation of a previously detailed masked intruder paradigm (46). 
Males were singly housed in holding cages and the “intruder” entered into the pen 
and stood about six feet in front of the cage making direct eye contact with the 
monkey. Emotional responsivity was rated by two experimenters blind to Rearing 
status using a 3-point scoring scale. To receive a score of one for intruder distress, 
subjects exhibited “confrontational” behaviors including: fang-baring, growling, direct 
eye contact, pilo-erection, ear flexing, cage shaking, and mouth gaping. The least 
distressed response received a score of “three” which was characterized by an 
animal that was minimally confrontational, averting eye contact, submissive and 
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displaying lip smacking, receding to the back of the cage and exhibiting “timidity” in 
response to the intruder. A score of two describes a subject with intermediate or 
alternating levels of both confrontational and timid behaviors. One hundred percent 
inter-rater reliability was observed for the intruder behavioral scoring system. 
 
Genotyping:  
Genotypes were determined by PCR amplification followed by size fractionation on a 
2% agarose gel (75). Primers used were CAG CAC CTA ACC CCC TAA TGT CCC 
TG and GAT TCT GGT GCC ACC TAG ACG CCAG. Each 10 μl reaction contained 
20 ng DNA, 1 μM of each primer, 1 M betaine, 10 μM dNTPs, and 0.1 unit KlenTaq 
polymerase, in manufacturer's PC2 buffer. Cycling parameters were 95°C for 5 min 
followed by 30 cycles at 95°/72° for 30 and 60 s respectively, using an MJR thermal 
cycler. 
Neurohistology:  
PKMzeta and BDNF Fluorescent: Left brain sections cut to 40Mm thickness were 
rinsed three times (5min) in PBS, pH 7.4, transferred to .2% PBST to permeabilize. 
Sections were then incubated for 10 min with 0.1% glycine in PBS to quench free 
aldehydes, and rinsed with PBS for 10 min. The sections were then incubated in 
blocking buffer (5% normal goat serum in PBS) for 1 h and then overnight in primary 
antibody (either PKMzeta or BDNF @ 1 : 200) in blocking buffer (a–c), or blocking 
buffer alone as control (d). The sections were then rinsed in PBS, four times for 20 
min each and incubated with goat anti-rabbit Alexa Fluor 488 (1 : 200) in blocking 
buffer overnight on a rotator at room temperature in the dark. The sections were 
rinsed three times in PBS, washed in distilled water and mounted with DAPi 
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Vectashield Mounting Medium on glass slides with Prolong Gold (Molecular Probes, 
Eugene, OR, USA). Negative control was hippocampal tissue without primary 
antibody.  
PKMzeta Peroxidase: Sections of the left hippocampus was removed from 
cyroprotectant, heat-induced epitope retrieval boiling in citrate buffer ph 6.0, washed 
in .2% PBST, peroxidase activity quenched with 2% H202, blocked in Normal 
Serum, incubated in Primary Antibody @ 1:500 (Rabbit Anti-PKMzeta, Provided by 
Dr. Todd Sacktor, SUNY Downstate) for 72hrs, washed in .2% PBST, Incubated in 
Secondary antibody @ 1:200 (Biotinylated Goat-Anti Rabbit, Vector Labs), Incubated 
in avidin-biotin solution (ABC elite, Vector Labs), chromagen developed using DAB 
(vector labs), mounted on subbed slides, counterstained with Neutral Red (vector 
labs), dehydrated, cleared, and coverslipped with DPX mountant (Sigma). Negative 
control was hippocampal tissue without primary antibody.  
 
Quantification of Average Signal Intensity:  
Hippocampal slides were imaged with using an Olympus BS 52 research 
microscope fitted with the Olympus DP72 camera at 10x. In order to achieve 
appropriate images for quantification, images had to be processed before cell-
counting program could be applied to optimize resolution, artifacts, and uneven 
fluorescence. These parameters were optimized for each group of control and 
experimental animals to account for differences in tissue quality. Images were 
analyzed using ImageJ to quantify PKMzeta or BDNF-labeled cells. Briefly, 
background noise was subtracted using averaged ROI measures from blank slide, 
 20 
image was converted to grayscale, and each subregion of the hippocampus was 
traced out using rhesus monkey atlas (no bonnet atlas exists).  
Mean PKMzeta Signal Intensity by hippocampal subregion: Adapted from Dr. 
Sacktor’s methods, ROIs of each subregion were traced out, and mean signal 
intensity was calculated using ImageJ analysis software. 
 
Figure 4: Example of ROIs traced for each hippocampal subregion. Image shows Control Animal 
(Non-VFD, Long allele) PKMzeta IF test, showing localization of PKMzeta in green in hippocampus.  




ImageJ Method Validation: Protocols were validated using independent rater 
counts. Two independent raters, blind to experimental condition of animal, 
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conducted all measurements of total PKMzeta and BDNF counts manually. The total 
number of unambiguously labeled PKMzeta+ or BDNF+ cells in each sub-region was 
counted. For both counts, either ImageJ-generated or manual, the total number of 
counted cells was divided by the volume of the subregion (area of each region 
measured by ImageJ in µm X 40 µm thickness before post-mounting shrinkage of 
50%–70%) (see Figure 5). Rates of labeled cells were expressed as a density per 
mm3 of the given subregion. Images taken using an Olympus BS 52 research 
microscope fitted with the Olympus DP72 camera.  
 
 
Figure 5: Validation of ImageJ PKMzeta+ Cell Counting Method Right graph shows comparison of 
manual count vs. ImageJ count over 6 separate specimens. Left graph shows correlation between two 
counting methods. (p = 0.0006) 
 
Statistical Analysis:  
Males: PKMζ Intensity Signal in Subregions of the Nonhuman Hippocampus:  A 





































Validation of ImageJ PKMz+ Cell Counting Quantification 
Method, Control Animal, CA3 region
Manual Count
ImageJ Count
 ImageJ:manual:   r = 0.9802, p = 0.0006

















(n=4), VFD long (n=2), and LFD long (N=4)] as the categorical variable, based on 
the subjects’ serotonin transporter gene (STG) polymorphism status.  No subjects 
were available for the” LFD -short group”, which prohibited use of a factorial ANOVA.  
Subregions of the hippocampus were used as repeated measures.  Post-hoc effects 
were examined using Newman-Keuls testing. 
Females: A GLM was employed in normally reared females using concurrent stress 
versus no stress as the categorical variable and hilar PKMZETA mean signal 
intensity in the hilar subregion of the hippocampus as the dependent variable.  Age  
[years: mean (SD) = 9.13 (3.20)] and   weight  [kg: mean (SD) = 8.58   (3.03)] were 
confounds and not used as covariates. 
Relationship of Hippocampal Subregional PKMzeta to Behavioral Response to a 
Human Intruder: For males possessing PKMzeta mean signal intensity data, acute 
behavioral response to a human intruder, prior to sacrifice, was grouped into 
confrontational (N=3) or timid (n=6).  Using a GLM, the categorical variable was 
defined by nature of acute behavioral response, confrontational versus timid, 
whereas subregions of the hippocampus were used as repeated measures.   
Interaction of Concurrent Stress an Serotonin Transporter Gene Polymorphism: 
Effect of SSRIs A GLM was performed using two categorical variables – Condition: 
No Stress + placebo (N=4), Stress + placebo (n = 7) and stress + fluoxetine (N=4) – 
whereas the second categorical variable was serotonin transporter gene 
polymorphism [short (N = 7) versus long (N = 8)] and using a factorial ANOVA, their 
interaction. The repeated measures were PKMzeta mean signal intensity for the hilar 









Early Life Stress Interacts with Short Allele of Serotonin Transporter Gene 
to produce PKMzeta deficit across all Hippocampal Subregions in Male 
NHPs 
Our first specific aim was to detect and quantify average PKMzeta signal intensity in 
the NHP hippocampus across differentially reared subjects. Using a subset of our 
male NHP cohort (N=10), we first utilized IHC to detect and quantify the average 
signal intensity of PKMzeta protein in postmortem NHP fixed hippocampal tissues. 
Using the methods described above, each hippocampal subregion was traced out 
according to the rhesus macaque brain atlas (Figure 4).  We next compared the 
average PKMzeta signal intensity in six hippocampal subregions across three 
groups: Low Foraging Demand (LFD) + Long Allele Serotonin Transporter Gene 
(STG), VFD + Long STG, and VFD + Short STG. There was an overall group effect: 
(Group Effect F(2, 7)=30.36 p=.0.00035)–there was a marked reduction in 
PKMZETA signal mean intensity in the VFD-short allele group versus the other two 
groups, whereas the VFD-long allele and LFD-long allele were not statistically 
distinguishable.  For every hippocampal subregion the identical pattern of 
differences was evident on post-hoc testing (indicated by the asterisks in the figure 
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below).  Mean age of subjects (N=9; one value missing) = [mean (SD) = 8.88 (1.23) 
years] whereas mean weight of subjects [mean (SD) = 9.11 (2.83) kg].   No PKMzeta 
variable was significantly related to weight or age and therefore these were not used 
as covariates. Thus, there was a highly significant STG genotype x rearing effect – 
average PKMzeta signal intensity was severely reduced in all six hippocampal 
subregions in the VFD + Short STG group (Figure 6).  
 
Group  Effect: F(2, 7)=30.36 p=.0.00035
Vertical bars denote +/- standard errors
STG = serotonin transporter gene   * univariate testing: p < 0.05
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Figure 6: A combination of ELS + Short STG leads to reduced average PKMzeta signal intensity 




These results demonstrate that serotonergic signaling mediates a severe deficit in 
hippocampal PKMzeta expression in ELS subjects. Notably, neither ELS rearing nor 
Short STG allele alone was enough to affect PKMzeta expression. However, ELS in 
combination with the Short STG allele leads to a PKMzeta deficit. This is partially 
consistent with our main hypothesis, that ELS would negatively affect PKMzeta. 
However, this effect appears to be mediated through serotonergic alterations. 
Interestingly, in a previous study (77) we have reported that VFD animals experience 
abnormal serotonin neurotransmission to forebrain regions from midbrain 
serotonergic nuclei. Given these results, we posit that while this effect is not 
sufficient to reduce PKMzeta in adulthood on its own, additional perturbations to 
serotonin signaling due to impaired serotonin transporter function can cause 
significant attenuation in PKMzeta expression. These results then lead us to ask if 
reduced PKMzeta expression in VFD + Short STG animals was associated with 
changes in behavioral phenotypes.   
Figure 7: Reduced PKMzeta expression in VFD Short STG (A) Shows VFD Short STG Allele subject 
PKMzeta peroxidase test for intracellular localization, showing PKMzeta in brown in CA3 region. 
Magnification 40x. (B) Shows Control Animal (Non-VFD Long allele)  
  




Decreased PKMzeta Signal Intensity in VFD + Short STG subjects is 
Correlated with Behavioral Timidity 
We next set to investigate if there is a relationship between hippocampal PKMzeta 
expression observed in the VFD + Short STG and our previously obtained behavioral 
measures in these subjects. We hypothesized that reduced PKMzeta would translate 
to changes in behavior that may stem from reduced LTP maintenance, and in turn, 
reduced capacity for hippocampal processing. When we examined average 
PKMzeta signal intensity across all 6 subregions of the hippocampus and compared 
these values to our behavioral measures of emotional reactivity, we found a 
significant correlation between reduced PKMzeta expression and behavioral timidity 
– a maladaptive, anxiety-like behavior in male bonnet macaques (Figure 8). An 
overall group effect was observed [F(1,7) = 6.29, p = 0.04] indicating that the 
confrontational nature of response was associated with greater PKMzeta signal 
overall in comparison to the timid group. In addition, a repeated measures by group 
effect was observed [F(5,35) = 3.02, p = 0.022].  Using post-hoc t-tests, significant 
group effects were noted for the zona moleculare, dentate gyrus and CA3 
subregions of the hippocampus (see * in the figure below) whereas differences 
tapered off toward the subiculum.  Group effects remained significant when 
covarying for weight whereas repeated measures x group effects remained 
significant when covaried for age. Timidity is described as a subordinate behavior, 
with the subject displaying low emotional reactivity to direct confrontation with an 
intruder. This is in contrast to the more typical male bonnet macaque response – a 
demonstration of confrontation and distress at an intruder. Furthermore, subjects 
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that displayed a confrontational response to intruder had significantly higher 
PKMzeta expression across all hippocampal subregions. Together, these results 
suggest that PKMzeta levels in the hippocampus are linked to affective processing – 
lower PKMzeta is associated with anxiety-like behaviors.  
 
Repeated Measures x Group Effect: F(5, 35)=3.02, p=.022
Vertical bars denote +/- standard errors


































Figure 8: Reduced PKMzeta expression is associated with anxiety-like behaviors in response to 
intruder confrontation across all hippocampal subregions in NHP males 
 
Chronic Adult Separation Stress Leads to Reductions in Average PKMzeta 
Signal Intensity in the Hilus Region of the Female NHP Hippocampus 
In order to compare the relative effects of ELS versus chronic adult stress, we next 
investigated the effects of adult stress (N=4) on average PKMzeta signal intensity in 
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our female cohort of NHPs compared to non-stressed control animals (N=7). 
Interestingly, we found that concurrent, chronic adult stress severely reduces 
average PKMzeta signal intensity in the NHP hilus region of the hippocampus (p = 
.018) (Figure 9) in female subjects.  Due to time constraints, we were not able to 
quantify all six subregions of the female NHP hippocampus. However, in our 
analysis with the male cohort, all six subregions followed the same correlative 
pattern, with no regional effect differences. For this reason, we used the hilus and 
CA3 regions in the female NHP subjects as representative ROI. The concurrent 
stress condition was associated with a significant reduction in hilar subregion of 
PKMZETA signal mean intensity (see stats in Figure 9). Overall, while ELS alone did 
not significantly affect PKMzeta expression later in life (Figure 6), concurrent stress 




Current effect: F(1, 9)=8.16, p=.018






































Age at Sac: 8.58 years
 
Figure 9: Concurrent Adult Stress reduces PKMzeta Average Signal Intensity in Female NHP Hilus 
Control animals did not undergo any stress paradigms and were normally housed. Stress animals were 
subjected to the standard separation stress paradigm, described in Methods. 
 
The Short STG allele leads to decreased PKMzeta expression in the Hilus + 
CA3 Subregions of Female Stressed NHP Hippocampus compared to Long 
STG Allele Subjects 
Having established that concurrent stress decreases PKMzeta expression in the 
hilus region of Long allele STG subjects, we next asked if STG genotype modulates 
PKMzeta expression in the female in a similar fashion as it did in the male cohort. 
Thus, we looked at PKMzeta signal intensity in the hilus and CA3 regions of female 
subjects that underwent concurrent adult stress and examined the effects of the 
Short STG allele vs. the Long STG allele. We found a highly significant correlation 
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between the Short STG allele and decreased PKMzeta signal in the hilus and CA3 
regions of the hippocampus, indicating that in animals experience chronic adult 
stress, the Short STG allele mediates a further reduction in PKMzeta expression.  
 
Group effect: F(1, 3)=95.294, p=.0022






































Weight (kg): 5.1 
 
Figure 10: STG genotype Mediates Average PKMzeta Signal Intensity in Concurrently Stressed 
Adult Female NHP. Figure shows the PKMzeta signal intensity means for the Hilus + CA3 region, for both 
Short STG allele subjects and Long STG allele subjects.  
 
Increasing Hippocampal Serotonin via Fluoxetine Increases PKMzeta 
Expression in Hilus of Chronically Concurrently Stressed Short STG NHP 
Female Hippocampus Compared to Placebo Stressed Short STG Subjects 
Next we observed how PKMzeta expression would be affected by administration of 
the Selective Serotonin Reuptake Inhibitor (SSRI) Fluoxetine, a pharmacological 
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agent that blocks the serotonin transporter, increasing the amount of extracellular 
serotonin available and potentiating the signal strength of serotonergic transmission. 
Based on our findings, STG genotype plays a role in modulating PKMzeta 
expression after both ELS (Figure 6) and adult concurrent stress (Figure 10). We 
thus hypothesized that increasing the amount of serotonin available in the 
hippocampus via fluoxetine would increase the amount of PKMzeta signal detected.  
We obtained the average PKMzeta signal intensity of the Hillus + CA3 regions in 
NHP females and compared these measures across six groups: No Stress + 
Placebo (Short and Long STG allele); Concurrent Adult Stress + Placebo (Short and 
Long STG allele); and Concurrent Adult Stress + Fluoxetine (Short and Long STG 
allele). SSRI treatment, for the short allele, has no discernable effect whereas for the 
long allele, SSRIs appear to reduce PKMZETA signaling into the range of values 
observed with the short allele, and is significantly less (see asterisk) than the other 
two long allele groups – No Stress + Placebo and Stress + Placebo.   The fluoxetine 
effects are counterintuitive in comparison to human data in which SSRIs appear to 
perform optimally in depressed subjects with the long allele, and not to reduce the 
expected value (1). The results are shown in Figure 11; on the left side of the graph, 
the measures for the Short Allele STG animals were consistent with our hypothesis. 
Administration of the SSRI fluoxetine increased PKMzeta expression to Control 
levels in the Stress + Short Allele STG group. Thus, increasing serotonin also 
increased PKMzeta signal intensity in these two hippocampal subregions in 
stressed, Short STG Allele subjects. Interestingly, we found a contradictory effect in 
the Long STG allele group. Although concurrent adult stress did reduce PKMzeta 
expression compared to control animals (as previously shown), subjects that 
received fluoxetine had severely reduced levels of PKMzeta. This was an 
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unexpected result, and suggests that fluoxetine has differential effects on PKMzeta 
expression in Short versus Long STG allele stressed subjects.  
stress*genotype interaction 
Current effect: F(2, 9)=13.75, p=.0018









































Figure 11: Fluoxetine increases PKMzeta expression in Hilus + CA3 compared to Placebo in 
Concurrent adult stress + Short STG allele female NHPs, but NOT in Long STG allele subjects.  
 
Increasing Hippocampal Serotonin via Fluoxetine Increases BDNF 
Expression in Hilus of Concurrently NHP Female Hippocampus Compared 
to Placebo Stressed Subjects 
Finally, we used IHC to detect and quantify BDNF average signal intensity in the 
female NHP hippocampus in order to determine if BDNF expression is linked to 
serotonergic signaling in these same subjects. In our previous study, we outlined a 
putative model for serotonergic dysfunction in the VFD NHP, in which attenuated 
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serotonin neurotransmission from the dorsal raphe nucleus to forebrain limbic 
regions resulted in compromised neurotrophic activity (77). This model is drawn from 
preclinical reports (59,60) that the main trophic factor responsible for maintaining 
neuronal growth and integrity, BDNF, is intimately connected with serotonin 
signaling. Thus, we hypothesized that increasing hippocampal serotonin via SSRI 
fluoxetine administration would result in increased BDNF expression. In Figure 12, 
we show that BDNF expression is significantly increased in the Hilus of concurrently 
stressed female NHPs with fluoxetine, compared to subjects given a placebo. Thus, 
when serotonin is putatively increased, BDNF is also increased. This data supports 
our hypothesis that low serotonin may lead to low BDNF levels, leading to reduced 
neurotrophic activity and LTP capacity through BDNF’s mediation of PKMzeta.  
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Group Effect: F(1, 5)=3.72, p=.11, partial Eta Squared = 0.42 
Effective hypothesis decomposition
Vertical bars denote +/- standard errors




































Figure 12: Regardless of STG genotype, SSRI Fluoxetine increases BDNF expression in concurrently 
stressed female NHP hilus, compared to subjects receiving placebo.  
Conclusions 
 
1. In Male NHPs, ELS + Short STG allele is correlated with PKMzeta 
expression deficit across hippocampus, a deficit associated with 
anxiety-like behaviors 
2. In Normally-Reared Female NHPs, Adult Concurrent Stress Reduces 
PKMzeta Expression in the Hippocampus, an Effect Exacerbated by 
Short STG allele and Relieved by SSRI administration 
3. Hippocampal PKMzeta Expression is Associated with Serotonergic 
Function in Both Male and Female NHP Cohorts, Revealing a 
Connection to Both ELS and Concurrent Adult Stress 
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In Male NHPs, ELS + Short STG allele is correlated with PKMzeta 
expression deficit across hippocampus, a deficit associated with anxiety-
like behaviors 
In this study, we first present data indicating that ELS in combination with the Short 
STG allele negatively regulates PKMzeta expression in the male NHP hippocampus. 
Our initial hypothesis predicted that ELS would lead to decreased PKMzeta in the 
adult subjects – however we found that ELS alone was not sufficient to produce a 
PKMzeta deficit into adulthood, when PKMzeta expression was measured across six 
hippocampal subregions via IHC. Interestingly, in VFD subjects harboring the short 
STG allele, we found significant decreases in PKMzeta expression compared to VFD 
subjects with the Long STG allele or Control animals. These data indicate that 
PKMzeta expression in ELS animals may be mediated directly by serotonergic 
signaling. These findings extend our previous work showing gene by environment 
(short allele by ELS) effects in nonhuman primates exposed to VFD-rearing for 
reduced corpus callosum cross sectional area (77) and CSF CRF concentration 
elevations (78). Additionally, these reports are consistent with rhesus macaque work 
from other groups showing a similar short allele by ELS interactions (i.e., peer 
rearing) on HPA reactivity in response to stress (79-81). Several studies 
investigating the influence of risk factors for depression and other stress-related 
psychiatric disorders have found a role for the short allele of the serotonin 
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transporter linked polymorphic region (5-HTTLPR) in increased vulnerability to these 
diseases (82). These studies suggest that the short STG allele may be linked to 
increased sensitivity to stress, starting early in life (83). It has found that the short 
allele STG genotype is linked to increased anxiety-related behaviors beginning in 
development, (84), and continuing into adolescence and early adulthood, providing a 
valid developmental model for understanding how the 5-HTTLPR short allele might 
modulate stress reactivity.  
In the current study, we find that the short STG genotype mediates reduced 
PKMzeta expression in the hippocampus when present in animals reared in a VFD 
ELS paradigm, suggesting that this allele may also be contributing to LTP 
maintenance and cognitive processes in these subjects. Supporting this hypothesis, 
we found that reduced PKMzeta expression in these same subjects was associated 
with timidity and anxiety-like responses to an intruder stressor task. This timid, 
maladaptive response to intruder stress has been found to be indicative of an 
increased susceptibility to various forms of affective disorder (85). Indeed, based on 
a wide body of work, a conceptual framework has been developed that suggests that 
differences in behavioral strategies to deal with this same intruder paradigm may 
have implications in terms of vulnerability to stress-related pathologies (85). Here, 
we report that STG genotype interacts with ELS exposure to reduce PKMzeta, which 
directly predicts the patterns and types of behavioral responses that NHP subjects 
exhibit to an acute stressor. This finding supports the hypothesis that PKMzeta 
expression in the hippocampus may be used as a marker of affective processing, 
and may represent a potential target for therapeutic applications in the treatment of 
psychiatric disorders related to stress.  
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In Normally-reared Female NHPs, Adult Concurrent Stress Reduces PKMzeta 
Expression in the Hippocampus, an Effect Exacerbated by Short STG allele 
and Relieved by SSRI Administration 
Another intriguing result from this study was the finding that adult concurrent stress 
reduces hippocampal PKMzeta expression in normally-reared female NHPs. This 
finding is consistent with our previous work on this same female NHP cohort, 
showing a variety of stress-related neurobiological alterations (50). Notably, we have 
published data showing that adult concurrent stress leads to depression-like 
anhedonia behaviors in these animals (50) – a finding that supports our current 
finding of PKMzeta being linked to behavior (in male NHPs) and its role as a marker 
of affective processing. In that paper, exposure of monkeys (Stress-Placebo group, 
n = 3) to repeated social separation stress led to gradual increases in behavioral 
scores for anhedonia (a behavioral composite of collapsed postures, inactivity, and 
blank stares) and decreases in scores for hierarchy (total subordinate behaviors 
subtracted from total dominant behaviors) (50). The bonnet macaques exposed to 
repeated social separation stress displayed increases in anhedonia that involved a 
cluster of symptoms typically seen in depressive monkeys (86), including 
macaques (87). Critically, this behavioral profile possesses significant face validity 
as an analog of clinical anhedonia, a core symptom of major depression (88). The 
increases in the anhedonia scores were accompanied by decreases in hierarchy 
scores. Social subordinance is a hallmark of both chronic anxiety and depression in 
monkeys (86). This behavior of the NHPs in the setting of repeated social separation 
stress parallels clinical depression, as interpersonal loss is the predominant trigger 
of depression in humans (88) and chronic stress is a major epidemiological risk 
factor for major depression and chronic anxiety disorders (88).  
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Building on this finding, we next turned to compare the effects of the STG allele in 
concurrent adult stress subjects. Based on our pervious findings in the male NHP 
cohort, we predicted that the short STG allele would combine with concurrent adult 
stress to further decrease PKMzeta expression in the hippocampus of stressed 
females.  
One of the most important findings in this report is the contribution of STG 
transporter genotype in mediating PKMzeta expression in both ELS (male) and 
normally-reared animals subjected to concurrent adult separation stress (female). As 
discussed above, ELS + short STG allele reduced PKMzeta expression, and was 
correlated with anxiety-like behaviors. In our female NHP cohort, we found that while 
concurrent adult stress alone affected PKMzeta expression in the hippocampus 
compared to control animals. Investigating further, we looked at PKMzeta expression 
in Long vs. Short STG allele animals in this cohort of concurrently stressed subjects, 
we found that, as in the males, Short STG allele exacerbated the negative effects of 
stress on PKMzeta hippocampal expression, even further reducing PKMzeta 
expression in both subregions examined (hilus + CA3) below levels found in Stress + 
Long STG allele subjects.  
In several previous studies, we have reported that administration of the SSRI 
fluoxetine improves several depression-like symptoms in this cohort of bonnet 
macaque females (50), including measures of neurogenesis and anhedonia-related 
behaviors (50). Thus, we utilized this group of SSRI-treated animals in order to 
compare PKMzeta expression in these animals versus stressed, placebo-treated 
animals. We reasoned that due to our previous findings that serotonin transporter 
function is clearly tied to PKMzeta expression in both ELS and normally-reared 
concurrent adult stress conditions, increasing serotonin via SSRI treatment would 
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increase PKMzeta expression compared to the placebo group. Indeed, we found that 
in short STG allele females that were subjected to concurrent adult stress, treatment 
with SSRIs increased PKMzeta expression over the levels seen in the placebo-only 
stressed group. It is important to note that we did not see the same effect in stressed 
animals harboring the Long STG allele – that is, Stress + Long STG allele + Placebo 
subjects had higher PKMzeta expression than Stress + Long STG allele + SSRI. 
This was an unexpected result, and not consistent with our hypothesis. However, in 
a recent study (unpublished results) we have seen several counterintuitive results in 
this same cohort of female NHPs between the placebo and SSRI groups, indicating 
that fluoxetine affects different groups in unpredictable ways. Much further analysis 
and study is needed in order to fully characterize the effects of SSRIs in differential 
STG genotype subjects. Nevertheless, there was a significant effect in the Short 
STG allele group with PKMzeta expression comparing Placebo vs. SSRI conditions. 
Given these results, we have begun to develop a putative model for the connection 
between serotonergic signaling and PKMzeta expression in the NHP hippocampus 
in stress conditions.  
 
Hippocampal PKMzeta Expression is Associated with Serotonergic 
Function in Both Male and Female NHP Cohorts, Revealing a Connection to 
Both ELS and Concurrent Adult Stress 
Previously, in a NHP model of ELS, our laboratory has found evidence of an 
intriguing mechanistic connection between serotonergic neurotransmission to the 
hippocampus and PKMzeta-mediated LTP, putatively bridged by the highly important 
neurotrophin brain-derived growth factor (BDNF). This relationship between the 
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serotonin system, PKMzeta, and BDNF may explain many of the neurobiological 
symptoms observed post-ELS, and elucidate the pathophysiology of affective 
disorder.   One of the major consequences of VFD rearing we have focused on in 
our research is dysfunctional serotonin neurotransmission. The serotonergic system 
is crucially important to the pathophysiology and the treatment of mood disorders, 
and its disruption in ELS may underlie the increased risk of depression and anxiety 
(55, 45). Accordingly, one genetic risk factor that contributes to increased 
vulnerability to depression is the SLC6A4 serotonin transporter gene, which is critical 
to the regulation of serotonin function throughout the brain. The “s” allele encodes an 
attenuated promoter segment, and is associated with reduced transcription and 
functional capacity of the serotonin transporter (89). In bonnet macaques, this 
endogenous single nucleotide polymorphism is conserved, allowing us to study the 
effects of serotonin neurotransmission in our ELS animal model. In our cohort of 
VFD and non-VFD subjects, we have reported a gene x environment effect for both 
CSF CRF concentration, and amygdala volume (77,78). Thus, the short allele of the 
5-HTTLPR is linked with an increased risk for developing symptoms associated 
affective disorder after ELS, pointing to the important role of serotonergic signaling in 
modulating these processes. Additionally, we have found elevated cisternal, peri-
raphe CSF 5-HIAA in three separate cohorts of VFD animals compared to normally 
reared controls, which we hypothesized reflects a form of serotonin 
neurotransmission dysfunction specific to ELS (54). ELS persistently activates 
stress-mediated circuitry, compromising these networks’ responses to future stress 
(1,56). A particularly relevant example of such circuitry is the glutamatergic afferents 
emanating from Layer V of the medial prefrontal cortex to stimulate serotonin release 
in the midbrain raphe nuclei (57). Stress-induced excess serotonin release may 
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trigger an endogenous negative-feedback mechanism mediated by serotonin 5-
HT1A autoreceptors in the raphe itself (57,58) reducing serotonin projections to 
critical forebrain areas such as the hippocampus. In support of this model, we have 
previously found that high VFD cisternal 5-HIAA measures correlated with reduced 
right hippocampal volume, indicating downstream neurotrophic effects (77). The 
mechanisms responsible for these effects, however, are not currently understood. In 
the current report, we suggest that stress, both during early life and in adulthood, 
negatively affects serotonin signaling, leading to downstream consequences, 
particularly with regard to neurotrophic activity.  
 
SSRI treatment is Related to Increased BDNF Expression in the Female NHP 
Hippocampus  
The current study aimed to determine if PKMzeta, and by extension, LTP 
maintenance, has a role in mediating the neurobiological symptoms of ELS-induced 
affective disorder. Preclinical studies of the effects of stress suggest a minimum of 
four mechanisms by which hippocampal atrophy may result from stress: dendritic 
atrophy, synaptic remodeling (synaptic overproduction and pruning), increased 
neuronal death, and decreased rates of neurogenesis (90-92), all processes that are 
intimately tied to BDNF and serotonergic signaling (59,60). Indeed, hippocampal 
volume is closely reliant on the presence of neurotrophic factors such as brain-
derived growth factor (BDNF) to maintain neuronal growth and survival (59). 
Importantly, this key growth factor has a synergistic relationship with the serotonin 
system, regulating serotonergic neuronal survival even while serotonin-activated 
second messengers modulate BDNF production (59-62). In fact, the hippocampus is 
particularly vulnerable to changes in BDNF level; missense polymorphisms in the 
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BDNF gene are directly correlated with reduced hippocampal volume (63). These 
data imply that reduced serotonin neurotransmission at the hippocampus is directly 
linked to reduced volume through BDNF production (60).   
 
BDNF has a Central Role in Memory and Regulates PKMzeta During LTP  
As described above, our previous research has suggested a connection between 
serotonergic dysfunction precipitated by ELS and reduced neurotrophic activity in the 
hippocampus, which is mediated by BDNF. BDNF has a well-documented role in 
mediating LTP in the hippocampus (65) and other regions involved in memory, such 
as the amygdala (64). Importantly, BDNF has been found to be required not only for 
acquisition but also for persistent storage of long-term fear memory (66). In fact, 
BDNF can rescue LTP even when protein synthesis is inhibited, demonstrating that 
the factor is both necessary and sufficient for expression of synaptic potentiation 
(67). A recent study by Sacktor et al. (68) reported a mechanistic explanation for this 
finding – in acute mouse brain slices, they showed that inhibition of PKMzeta 
reversed this BDNF-dependent form of LTP. Molecular analyses revealed that BDNF 
can maintain levels of PKMzeta at the synapse through directly associating with it, 
and preventing its degradation, allowing for continued trafficking of AMPARs to the 
post-synaptic density even when PKMzeta cannot be synthesized (68). Additional 
studies have confirmed this relationship between BDNF and PKMzeta, 
demonstrating that BDNF enhances PKMzeta expression, controls PKMzeta nascent 
synthesis via translation machinery mTORC1, and also enhances PKMzeta 
phosphorylation and activation (69).  
In support of our model of BDNF bridging the connection between serotonin and 
PKMzeta, here we present evidence that BDNF levels are directly connected with 
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serotonergic levels- increasing extracellular serotonin and serotonergic signaling via 
SSRI administration increased BDNF expression in the hippocampus of NHP female 
subjects for both control and stress conditions.  
Taken together, these data lay the foundation for a model in which ELS-related 
serotonergic dysfunction leads to reduced BDNF in the hippocampus, compromising 
neurotrophic activity and negatively affecting regulation of PKMzeta, the only known 
molecule to be necessary and sufficient for LTP and long-term memory storage (70). 
While many of the structural and neurochemical consequences of ELS have been 
studied, it is not well understood exactly how these changes might translate to the 
deficits in cognitive and affective function associated with mood disorders. By 
connecting our previous findings of serotonergic dysfunction in the VFD model to the 
neurotrophic hypothesis of depression, we conclude that PKMzeta expression may 
be negatively affected post ELS in subjects with compromised serotonergic 
signaling, and this effect may lead to reduced cognitive and affective processing. 
 
Given these findings, we propose that studies in nonhuman primates provide an 
essential tool to understand the molecular mechanisms by which ELS interacts with 
the short allele to modify vulnerability to depression and anxiety in humans. 
Limitations of the study include the relatively small number of subjects, particularly 
for the gene by environment component. However, we acknowledge the preliminary 
nature of these findings of the interaction of ELS and the serotonin transporter gene 
in PKMzeta expression contributing to maladaptive, anxiety-like behaviors. 
Nonetheless, the current study adds to a growing body of data that suggests ELS is 
associated with a concert of biological changes that are evident across the lifecycle. 
The VFD paradigm provides an important animal model to elucidate the cellular and 
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molecular mechanisms by which ELS causes clinically relevant neurobiological 
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